SEC Filing

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

Diane H. Schrick
Senior Director, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
Jun 2, 2020
Document Date
Jul 30, 2020
Form Description
A preliminary proxy statement providing notification matters to be brought to a vote
Filing Group
Proxy Filings
Company
Jazz Pharmaceuticals plc
Issuer
Jazz Pharmaceuticals plc